Duncker Streett & Co. Inc. Trims Stock Holdings in Axon Enterprise, Inc $AXON

Duncker Streett & Co. Inc. trimmed its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 54.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,415 shares of the biotechnology company’s stock after selling 5,260 shares during the period. Duncker Streett & Co. Inc.’s holdings in Axon Enterprise were worth $1,875,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Clare Market Investments LLC acquired a new stake in shares of Axon Enterprise during the first quarter worth approximately $9,731,000. Nvest Financial LLC acquired a new stake in Axon Enterprise in the first quarter valued at $299,000. Whittier Trust Co. of Nevada Inc. raised its holdings in Axon Enterprise by 2.4% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 11,464 shares of the biotechnology company’s stock valued at $4,735,000 after acquiring an additional 266 shares in the last quarter. Whittier Trust Co. boosted its stake in Axon Enterprise by 9.9% during the 1st quarter. Whittier Trust Co. now owns 22,834 shares of the biotechnology company’s stock valued at $9,432,000 after acquiring an additional 2,058 shares during the last quarter. Finally, Ascentis Independent Advisors bought a new position in Axon Enterprise during the 1st quarter valued at $539,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Axon Enterprise

In other news, President Joshua Isner sold 13,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $488.45, for a total value of $6,349,850.00. Following the completion of the sale, the president directly owned 169,125 shares of the company’s stock, valued at approximately $82,609,106.25. This represents a 7.14% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $400.00, for a total transaction of $800,000.00. Following the transaction, the insider owned 52,813 shares in the company, valued at $21,125,200. This represents a 3.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 48,989 shares of company stock worth $24,090,083 over the last ninety days. Insiders own 4.20% of the company’s stock.

Axon Enterprise Stock Up 2.9%

Axon Enterprise stock opened at $640.46 on Wednesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91. The company has a 50-day simple moving average of $447.14 and a 200-day simple moving average of $483.02. The firm has a market capitalization of $51.62 billion, a P/E ratio of 257.21, a P/E/G ratio of 12.70 and a beta of 1.38.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.90 million. During the same period in the previous year, the business posted $1.47 EPS. Axon Enterprise’s revenue was up 33.7% on a year-over-year basis. As a group, equities analysts expect that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Needham raised its price target on Axon to $750 from $600 and reiterated a buy rating, arguing that Axon’s premium valuation is justified by the durability of its bookings growth and multiple expansion potential. Needham Bets Axon’s Premium Is Sustainable at $750
• Positive Sentiment: Axon extended its recent run after the Needham upgrade, with investors also encouraged by news that its Los Angeles Police Department contract expansion will more than double annual spending to $22 million. Axon Extends Win Streak On Target Hike, World Cup Drone Defense
• Positive Sentiment: Analysts continue to point to strong TASER, software, and counter-drone demand, and one report noted Axon crossing its 200-day moving average, which can reinforce bullish technical sentiment. Axon Crosses Its 200-Day SMA: Should You Buy the Stock Now?
• Neutral Sentiment: Several articles compared Axon’s year-to-date performance with aerospace and industrial peers, but these pieces were mainly market-performance snapshots rather than new company-specific catalysts. Is Axon Enterprise (AXON) Stock Outpacing Its Aerospace Peers This Year?
• Neutral Sentiment: One commentary piece argued Axon remains a hold despite AI momentum, suggesting valuation concerns may still temper some enthusiasm. Why Axon Remains A Hold Despite AI Momentum
• Negative Sentiment: A local political story about conservatives challenging Axon’s role in Scottsdale elections adds an element of reputational and regulatory noise, though it is less likely to move the stock than the analyst upgrades. Conservatives challenge Axon’s role in Scottsdale elections

Wall Street Analyst Weigh In

AXON has been the subject of several research analyst reports. UBS Group dropped their target price on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating for the company in a research report on Thursday, May 7th. The Goldman Sachs Group set a $535.00 price target on Axon Enterprise in a research note on Thursday, May 7th. Citizens Jmp restated a “market outperform” rating and set a $700.00 price objective on shares of Axon Enterprise in a research note on Thursday, June 25th. JPMorgan Chase & Co. increased their target price on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Finally, TD Cowen lowered their price target on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a report on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $722.12.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.